Mussurakis S, Sprigg A, Steiner G M
Department of Radiology, Sheffield Children's Hospital, Western Bank.
Clin Radiol. 1994 Aug;49(8):541-5. doi: 10.1016/s0009-9260(05)82933-2.
To determine the appropriateness of use and the clinical impact of micturating cystourethrography (MCU) in paediatric practice.
Retrospective medical record review.
A major teaching children's hospital in the Trent region.
Consecutive sample of 120 children undergoing MCU during 1991-1992, identified from the radiology records.
The referring clinician's reasons for requesting an MCU; the clinical management plan pursued before and after the MCU, and the change in management initiated by the result of the examination; the appropriateness of use of the test, as determined by the presence or absence of a valid indication for MCU in the specific clinical situation.
The change in patient management attributable to the MCU result could be categorized as: no change (19%); decision to end the imaging investigation of the patient (33%); decision to end all investigations, and prophylactic or therapeutic interventions (16%); decision to discontinue chemoprophylaxis (2%); decision to end the imaging investigation and introduce chemoprophylaxis and follow-up for bacteriuria (6%); decision to continue the imaging investigation and introduce chemoprophylaxis and follow-up for bacteriuria (13%); and decision to operate or help in planning the surgical treatment required (11%). Inappropriate use of the test was observed in 20% of the cases.
This study provides a basis for understanding the use of MCU in paediatric practice. The findings that 19% of the cystourethrograms had no appreciable effect, and that 20% of the examinations were used inappropriately show the need for increased effort to minimize overuse of the test.